A fast and easy way to find out about all new FDA approved cancer treatments.
Monday, February 25, 2013
Kadcyla now approved for HER positive breast cancer
Kadcyla (ado-trastuzumab emtansine) has been approved for the treatment of HER 2 positive metastatic breast cancer in patients who have not responded to Herceptin (trastuzumab) with chemotherapy.
No comments:
Post a Comment